← SynDRA
LERSIVIRINE
SynDRA canonical compound SYN0020311 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Mechanism of action | non-nucleoside reverse transcriptase inhibitor |
All known targets
Mechanisms of action (all sources)
- non-nucleoside reverse transcriptase inhibitor
- HIV RT INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ACHE
- ADORA1
- ADRB1
- ADRB2
- AGTR1
- DRD1
- DRD2
- HDAC6
- HRH1
- HTR1A
- HTR1B
- HTR2A
- KCNH2
- MAOA
- MAOB
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Cross-references
Synonyms
- Lersivirina
- UK-453,061
- UK-453061
- cc-718
- Lersivirine (UK-453061)
- UK 453061
- UK 453,061
- R3ZGC15A9A
- lersivirinum
- RefChem:798960
- DTXCID7031668
- UK453061
- UK453,061
- ZZE
- Lersivirine [USAN]
- Lersivirine [USAN:INN]
- UNII-R3ZGC15A9A
- 2won
- MFCD16619314
- LERSIVIRINE [INN]
- Lersivirine (USAN/INN)
- LersivirineUK 453061
- LersivirineUK 453061?
- LERSIVIRINE [WHO-DD]
- SCHEMBL508446
- orb1299580
- EX-A165
- CHEBI:177465
- GLXC-15729
- BDBM50483552
- AKOS030526818
- CS-1191
- FL65058
- SB17095
- NCGC00378968-01
- BS-17083
- DA-42388
- HY-14267
Look up LERSIVIRINE in the interactive SynDRA portal →